Expression of angiopoietin-1, angiopoietin-2, and Tie2 genes in normal ovary with corpus luteum and in ovarian cancer

Oncology

Volumn 62, Issue 4, 2002, Pages 340-348

  Hata, Kohkichi ^a   Udagawa, Jun ^a   Fujiwaki, Ritsuto ^a   Nakayama, Kentaro ^a   Otani, Hiroki ^a   Miyazaki, Kohji ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Angiopoietin 1; Angiopoietin 2; Corpus luteum; Gene expression; Ovarian cancer; Tie2

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; BETA 2 MICROGLOBULIN; MESSENGER RNA; TYROSINE KINASE RECEPTOR; TYROSINE KINASE RECEPTOR TIE2; UNCLASSIFIED DRUG;

ADULT; ANGIOGENESIS; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS LUTEUM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NUCLEOTIDE SEQUENCE; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

ADULT; AGED; ANGIOPOIETIN-1; ANGIOPOIETIN-2; CASE-CONTROL STUDIES; CORPUS LUTEUM; DNA PRIMERS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; OVARY; PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, TIE-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0036057578     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065066     Document Type: Article

References (22)

1. Vasculogenesis, angiogenesis and endothelial cell differentiation during embryonic development
2. Tumor angiogenesis
3. Angiogenesis
4. Angiogenesis in the female reproductive system
5. Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells
6. Vascularization of the mouse embryo: A study of flt-1, tek, tie, and vascular endothelial growth factor expression during development
7. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2
8. Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis
9. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues
10. Expression of TP and TIE2 genes in normal ovary with corpus luteum and in ovarian cancer: Correlation with ultrasound-derived peak systolic velocity
11. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization
12. Expression of the thymidine phosphorylase gene in epithelial ovarian cancer
13. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggesting a role in glioblastoma angiogenesis
14. Ovarian angiogenesis: Phenotype characterization of endothelial cells in a physiological model of blood vessel growth and regression
15. Isolation of angiopoietin-1, a ligand for the Tie2 receptor, by secretion-trap expression cloning
16. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
17. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2
18. Signaling vascular morphogenesis and maintenance
19. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transforming growth factor-β1-like molecule by plasmin during co-culture
20. Differential expression of markers for endothelial cells, pericytes, and basal lamina in the micro-vasculature of tumors and granulation tissue
21. Pericyte involvement in capillary sprouting during angiogenesis in situ
22. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis